Peraso enters agreement to sell up to $25M of common stock
Peraso entered a Common Stock Purchase Agreement with Roth Principal Investments on June 30, 2026. The deal permits Peraso to sell up to $25M of common stock to the investment firm.

*this image is generated using AI for illustrative purposes only.
Peraso entered a Common Stock Purchase Agreement with Roth Principal Investments on June 30, 2026, establishing a mechanism to sell up to $25M of common stock. The agreement provides Peraso with the option to offer shares to the investment firm at its discretion, subject to the terms outlined in the SEC filing.
Agreement Details
The Common Stock Purchase Agreement outlines the conditions under which Peraso may sell its shares to Roth Principal Investments. The total potential value of the transactions under this agreement is capped at $25M.
| Key Aspect | Details |
|---|---|
| Agreement Type | Common Stock Purchase Agreement |
| Counterparty | Roth Principal Investments |
| Date | June 30, 2026 |
| Maximum Value | $25M |
Strategic Implications
By entering into this agreement, Peraso secures a potential avenue for capital infusion. The arrangement allows the company to access funds through the sale of equity over time, depending on its financing needs and market conditions.
What specific strategic initiatives or R&D projects does Peraso plan to fund with the potential capital raised through this agreement?
How might the issuance of additional common stock under this agreement impact existing shareholders regarding dilution and earnings per share?
What market conditions or internal milestones will likely trigger Peraso's decision to exercise its option to sell shares?

























